Governor In Tight Political Spot On Stem Cell Research
By Associated Press,
Associated Press
| 08. 05. 2004
SACRAMENTO, Calif. -- Gov. Arnold Schwarzenegger appears to be in a tight political spot over Proposition 71, a bond measure that would provide $3 billion for human embryonic stem cell research in California.
Support Stem Cell Research?
Should Governor Take Position On Stem Cell Measure?
Schwarzenegger hasn't taken a position on the measure and many analysts believe he won't. That's because no matter which position he endorses, he's sure to alienate important constituents.
The measure promises to be one of the most contentious election issues this year.
It pits Nobel laureates, sympathetic patients who could benefit from stem cells and biotechnology interests against religious groups such as the Roman Catholic Church and political conservatives opposed to the research because it involves destroying days-old embryos and cloning.
Already, Proposition 71 is second only to the two gambling-related measures in campaign fund-raising. Supporters have raised more than $8 million while opponents have eked out less than $50,000.
Schwarzenegger has said he supports the technology. His father-in-law, Sargent Shriver, is in the early grips of Alzheimer's disease, which Proposition 71 supporters say could...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
